pyrrolidine has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gadhe, CG; Jeong, KS; Kim, GH; Lee, JY; Lim, EJ; Lim, KS; Lim, SM; Pae, AN; Son, WS; Yang, HK | 1 |
| Abram, M; Doboszewska, U; Kamiński, K; Latacz, G; Lubelska, A; Mogilski, S; Nieoczym, D; Pieróg, M; Socała, K; Szulczyk, B; Wlaź, P | 1 |
2 other study(ies) available for pyrrolidine and Neuralgia
| Article | Year |
|---|---|
Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; HEK293 Cells; Humans; Ligation; Male; Mice; Mice, Knockout; Molecular Structure; Neuralgia; Pyrrolidines; Rats; Rats, Sprague-Dawley; Spinal Nerves; Streptozocin | 2018 |
KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization.
Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Male; Mice; Molecular Structure; Neuralgia; Pentylenetetrazole; Pyrrolidines; Seizures | 2019 |